CytoMed Therapeutics Limited GDTC
Set alert
0.92 USD +0.02 +2.02%
At close · Oct 30
0.90 -0.02 -1.98%
After hours · Oct 30, 4:00 PM ET
0.8292 Day range 0.9188
0.723 52-week range 2.20
- YTD
- -31.43%
- 1 year
- -57.27%
- Open
- 0.8299
- Prev close
- 0.9006
- Mkt cap
- 10.97M
- Vol
- 11.44K
- Avg vol
- 19.11K
- EPS
- -0.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8292
- High
- 0.9188
- Forward P/E
- -15.80
- Beta
- 0.00
- Short ratio
- 7.54
- Inst. own
- 0.04%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.43
- 200-d avg
- 2.06
- 1y target
- 5.00
2Y chart
Signals (101)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2026 | 1 day ago |
| SMA: Bearish | Oct 29, 2026 | 2 days ago |
| SMA: Bullish | Oct 28, 2026 | 3 days ago |
| SMA: Bearish | Oct 27, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 1 month ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 9, 2026 | 4 months ago |
| RSI: Overbought | May 20, 2026 | 5 months ago |
| SMA: Bullish | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | May 15, 2026 | 5 months ago |
| RSI: Oversold | May 7, 2026 | 5 months ago |
| MACD: Sell Signal | May 5, 2026 | 5 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 24, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 17, 2026 | 6 months ago |
| SMA: Bearish | Apr 7, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| SMA: Bearish | Apr 2, 2026 | 7 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 31, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 26, 2026 | 7 months ago |
| SMA: Bullish | Mar 18, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 3, 2026 | 9 months ago |
| RSI: Oversold | Jan 26, 2026 | 9 months ago |
| RSI: Oversold | Jan 22, 2026 | 9 months ago |
| RSI: Oversold | Jan 13, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 8, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 29, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 26, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 9, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| SMA: Bearish | Oct 29, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 29, 2025 | 1 year ago |
| RSI: Overbought | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Oct 17, 2025 | 1 year ago |
| SMA: Bullish | Oct 14, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 14, 2025 | 1 year ago |
| SMA: Bearish | Oct 13, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 13, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 1, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 24, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 18, 2025 | 1 year ago |
| SMA: Bearish | Sep 16, 2025 | 1 year ago |
| RSI: Overbought | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 3, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 15, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 10, 2025 | 1 year ago |
| SMA: Bullish | Jul 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jun 24, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 4, 2025 | 1 year ago |
| SMA: Bearish | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| MACD: Buy Signal | May 27, 2025 | 1 year ago |
| MACD: Sell Signal | May 19, 2025 | 1 year ago |
| MACD: Buy Signal | May 14, 2025 | 1 year ago |
| MACD: Sell Signal | May 7, 2025 | 1 year ago |
| SMA: Bearish | Apr 10, 2025 | 1 year ago |
| SMA: Bullish | Apr 9, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| SMA: Bullish | Mar 24, 2025 | 1 year ago |
| SMA: Bearish | Mar 21, 2025 | 1 year ago |
| SMA: Bullish | Mar 20, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 7, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 20, 2025 | 1 year ago |
| SMA: Bullish | Feb 19, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 13, 2025 | 1 year ago |
| SMA: Bearish | Feb 12, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 31, 2025 | 1 year ago |
| SMA: Bullish | Jan 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 8, 2025 | 1 year ago |
| RSI: Overbought | Jan 2, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 27, 2024 | 1 year ago |
Key statistics
- Market cap
- 27.35M
- Enterprise value
- 23.15M
- Trailing P/E
- 0.00
- Forward P/E
- -15.80
- PEG ratio
- 0.00
- Price / sales
- 61.09
- Price / book
- 2.69
- EPS (TTM)
- -0.22
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 447.69K
- Revenue growth
- -21.10%
- Free cash flow
- -2.59M
- Total cash
- 6.82M
- Total debt
- 428.29K
- Return on equity
- -26.26%
- Shares outstanding
- 11.54M
- Short % of float
- 4.43%
- 50-day average
- 2.43
- 200-day average
- 2.06
Analyst view
Consensus: none
Price target (mean) 5.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.03.
Financials — quick view
GDTC Revenue — annual 324.39K
GDTC Net income — annual -3.98M
GDTC EPS — annual -0.34
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 10, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Jun 11, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Dec 4, 2023 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Jul 21, 2023 | Benchmark | init | — | Speculative Buy |
About CytoMed Therapeutics Limited
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore. The company was incorporated in 2018 and is headquartered in Singapore.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Singapore
- Website
- w2.cytomed.sg
News
- CytoMed Therapeutics Receives Nasdaq Noncompliance Notice
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Friday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 9 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- 12 Health Care Stocks Moving In Friday's After-Market Session
Your note
Sign in to keep a note on GDTC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 0.00% | 61 | 144 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.04% | 4,854 | 11.50K | Oct 30, 2024 |